Skip to main content
US EQUITIES AFTER-HOURS CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
ML

MLABStock

Nasdaq Global Select Market · Technology

$137.81 last close 2026-11-18
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment MLAB's does — no target price to set, unlike a price alert.

Stable Ratio screen, 7 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it

Sharia status
COMPLIANT
Per our in-house ratio engine
7 of 7 pass our own screen — all 7 agree here
Purification 0.00% *HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🟡 BULLISH LEAN
The main driver: outperforming the market by 12.2%, RSI in healthy zone. More signals pointing up than down. Not...
Scores: 3 bullish / 0 bearish
35
of 100
Setup confidence — system conviction, not win probabilityD

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

MOM · SCALP
Entry
$136.47
Stop
$135.11
Target
$139.20
Risk : Reward 2.0R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure1 of 5 timeframes bullish · 17.4% aligned
VWAPPrice holding above VWAP ($136.52)
VolumeRelative volume 3.6× the 20-day average
Momentum10-day rate of change +9.5%
Overall readBULLISH LEAN

MLAB is currently considered halal (Sharia-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 432 compliant Technology stocks we track. See compliant Technology stocks →

Market & analysts
Price target
$150.00
+8.8% · 1 analysts
Institutional own.
104.4% *
of shares
Momentum (10d)
+9.5%
rate of change
SMC grade
D · 35
17.4% aligned
0.00% *
Purification ratio (secondary provider, uncertain)
<0.01%
Non-permissible income — HTR, from filings (2026-09-30)
D · 35
SMC grade — 17.4% timeframe alignment
+9.5%
Rate of change (10d)
$150.00
Price target (+8.8%) · 1 analysts
104.4%
Institutional ownership *

How the status reached this point

Compliant · status tracked since Nov 17, 2026

No change to MLAB’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from our own screen, last on Nov 17, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $756.5M as of 2026-11-18.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 10.93% 30.00% Pass(19.1pp buffer)
Interest-bearing investments 2.95% 30.00% Pass(27.1pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Usmani Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 20.28% 33.00% Pass(12.7pp buffer)
Interest-bearing investments 5.47% 33.00% Pass(27.5pp buffer)
Non-liquid assets 84.87% at least 20.00% Pass(64.9pp above the floor)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 20.28% 33.33% Pass(13.1pp buffer)
Cash + interest-bearing securities 5.47% 33.33% Pass(27.9pp buffer)
Accounts receivable 15.13% 33.33% Pass(18.2pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
FTSE Pass 4 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 15.87% 33.33% Pass(17.5pp buffer)
Cash + interest-bearing securities 5.47% 33.33% Pass(27.9pp buffer)
Accounts receivable 15.13% 50.00% Pass(34.9pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Dow Jones Islamic Market Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 14.94% 33.00% Pass(18.1pp buffer)
Cash + interest-bearing securities 4.03% 33.00% Pass(29.0pp buffer)
Accounts receivable 7.12% 33.00% Pass(25.9pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 14.77% 33.00% Pass(18.2pp buffer)
Cash + interest-bearing securities 3.99% 49.00% Pass(45.0pp buffer)
Accounts receivable 7.04% 49.00% Pass(42.0pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 14.77% 33.33% Pass(18.6pp buffer)
Cash + interest-bearing securities 3.99% 33.33% Pass(29.3pp buffer)
Accounts receivable 11.02% 49.00% Pass(38.0pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

AAOIFI Standard 21 (% of market cap)non permissible income ratio 5.0pts
Usmani (% of total assets)non permissible income ratio 5.0pts
Dow Jones Islamic Market (% of 24-mo avg market cap)non permissible income ratio 5.0pts

The numbers the ratios are built from

Read from MLAB's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $249.1M 2026-09-30 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $64.7M 2026-09-30 LongTermDebt
Cash and interest-bearing securitiesCash, equivalents and marketable securities $22.3M 2026-09-30 CashAndCashEquivalentsAtCarryingValue
Total assetsBalance sheet total $407.7M 2026-09-30 Assets
Market capDenominator for AAOIFI $756.5M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $565.9M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $560.3M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-09-30 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-09, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-06-03, period ended 2026-09-30. Screened 2026-11-18.

  • Total assets$407.7M
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-09
  • Interest-bearing debt$64.7M
    LongTermDebt · period ended 2026-09-30 · 10-Q filed 2026-11-09
  • Cash and interest-bearing securities$22.3M
    CashAndCashEquivalentsAtCarryingValue · period ended 2026-09-30 · 10-Q filed 2026-11-09
  • Receivables$39.4M
    AccountsReceivableNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-11-09
  • Revenue$249.1M
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2026-03-31 · 10-K filed 2026-06-03
  • Interest income (non-permissible)$0
    no interest-income tag reported in 3+ years (treated as $0) · income statement as of 2026-09-30 · no filing link for this figure
  • Market cap$756.5M
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link

5 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for MLAB. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for MLAB has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 7 pass and 0 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-18.

No standard's deciding ratio sits within 3 points of its line.

The ratios that move with the share price

AAOIFI's debt ratio (10.9% against a 30% line) would only fail if the market cap fell by 64%, to $275.6M.

AAOIFI's investments ratio (2.9% against a 30% line) would only fail if the market cap fell by 90%, to $74.4M.

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Scientific & Technical Instruments listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
KYCCFKeyence Corporation $123.8B —
COHRCoherent Corp $53.9B —
KEYSKeysight Technologies Inc $53.1B —
GRMNGarmin Ltd $53.1B —
MKSIMKS Instruments, Inc. $18.2B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold MLAB

7 of the 216 funds whose filed holdings we currently hold own MLAB shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns MLAB.

You may already own it

Widely held U.S. index funds. If you own one, you own MLAB through it. None of them is a Shariah fund; the last column is our look-through of each.

FundMLAB in fundFund compliant by weight
SCHB Schwab U.S. Broad Market ETF 0.00% 53%
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00% 54%
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.00% 54%
Other funds
FundMLAB in fundFund compliant by weight
RMCFX Royce Micro-Cap Fund 0.42% 46%
IWO iShares Russell 2000 Growth ETF 0.03% 48%
PSIJX SmallCap Growth Fund I 0.00% 54%
TIEIX Nuveen Equity Index Fund Also TINRX 0.00% 51%

Sorted by MLAB’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names MLAB once, so a bond is not counted as the shares. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding MLAB
InvestorFirmPositionWeightAs of
Diamond Hill Diamond Hill Capital Management $17M 0.2% 2026-09-30
David Shaw D. E. Shaw & Co. $17M 0.0% 2026-09-30
Chuck Royce Royce & Associates $5M 0.0% 2026-09-30
Mario Gabelli GAMCO Investors $1M 0.0% 2026-09-30
Ken Griffin Citadel Advisors $1M 0.0% 2026-09-30
Joel Greenblatt Gotham Asset Management $1M 0.0% 2026-09-30
Caxton Associates Caxton Associates LLP $0M 0.0% 2026-09-30
Barrow Hanley Barrow Hanley Mewhinney & Strauss $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

142.23124.21106.1988.1770.152025-11-192026-05-212026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
130.21
S2
131.62
S1
133.11
PIVOT
134.52
R1
136.01
R2
137.42
R3
138.91

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
121.01 – 147.07
±9.72% from 134.04, made 2026-09-27 · resolves 2026-10-04
STRONG BUY
from 19 indicators
77.1% of our last 20463 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 50.1% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG BUY
19 indicators
OscillatorsSTRONG BUY
3 buy · 3 neutral · 1 sell
Moving averagesSTRONG BUY
12 buy · 0 neutral · 0 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)57.80NEUTRAL
Stochastic %K (14)79.30NEUTRAL
CCI (20)102.63SELL
Williams %R (14)-20.70NEUTRAL
MACD (12,26,9)0.90BUY
ROC (10)9.21BUY
Momentum (10)11.62BUY
EMA (10)134.07BUY
SMA (10)133.22BUY
EMA (20)131.92BUY
SMA (20)130.74BUY
EMA (30)130.66BUY
SMA (30)129.27BUY
EMA (50)128.07BUY
SMA (50)129.65BUY
EMA (100)121.05BUY
SMA (100)119.01BUY
EMA (200)108.63BUY
SMA (200)107.13BUY

About MLAB

Technology · Scientific & Technical Instruments

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

mesalabs.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-11-10

MOM
Type · SCALP
136.47
Entry
135.11
Stop
139.20
Target
LOSS
Outcome · exit 135.11 (-1.00%)

Stop 135.11 Now 137.81 Target 139.20

Verdict

🟡 BULLISH LEAN

The main driver: outperforming the market by 12.2%, RSI in healthy zone. More signals pointing up than down. Not full confluence yet, but the weight of evidence is bullish. Use `!alert MLAB [level]` to catch the entry, or `!plan MLAB` to size small.

Scores: 3 bullish / 0 bearish

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily RANGING 64
⏰ 4H NEUTRAL 20
🕐 1H BEARISH 81
⏱ 15-Min RANGING 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

+9.5%
Rate of change (10d)
3.6×
Volume vs its 20-day average
2.28
MACD (no fresh cross)
$138.07
Volume POC (today)
$136.87 – $138.54
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.